Department of Transplantation, Mayo Clinic, Jacksonville, FL 32224, USA.
Transplantation. 2011 Jul 15;92(1):31-5. doi: 10.1097/TP.0b013e31821c1e54.
Patients after liver transplant have a high incidence of chronic kidney disease and end-stage renal disease (ESRD). We investigated kidney transplantation after liver transplantation using the Organ Procurement Transplant Network database.
The Organ Procurement Transplant Network database was queried for patients who received kidney transplantation after previous liver transplantation. These patients were compared with patients who received primary kidney transplantation alone during the same time period.
Between 1997 and 2008, 157,086 primary kidney transplants were performed. Of these, 680 deceased donor kidney transplants and 410 living donor kidney transplants were performed in previous recipients of liver transplants. The number of kidney after liver transplants performed each year has increased from 37 per year to 124 per year in 2008. The time from liver transplant to kidney transplant increased from 8.2 to 9.0 years for living donor transplants and from 5.4 to 9.6 years for deceased donor. The 1, 3, and 5 year actuarial graft survival in both living donor kidney after liver transplant and deceased donor kidney after liver transplant are less than the kidney transplant alone patients. However, the death-censored graft survivals are equal. The patient survival is also less but is similar to what would be expected in liver transplant recipients who did not have ESRD. In 2008, kidney after liver transplantation represented 0.9% of the total kidney alone transplants performed in the United States.
Kidney transplantation is an appropriate therapy for selected patients who develop ESRD after liver transplantation.
肝移植患者慢性肾脏病和终末期肾病(ESRD)的发病率较高。我们使用器官获取与移植网络(OPTN)数据库研究了肝移植后的肾移植。
OPTN 数据库中检索了先前接受过肝移植后接受肾移植的患者。将这些患者与同期仅接受初次肾移植的患者进行比较。
1997 年至 2008 年期间,共进行了 157086 例初次肾移植。其中,680 例为已故供者肾移植,410 例为活体供者肾移植,这些患者先前均接受过肝移植。每年进行的肝移植后肾移植数量从 37 例增加到 2008 年的 124 例。活体供者移植的肝移植至肾移植时间从 8.2 年增加到 9.0 年,已故供者移植的肝移植至肾移植时间从 5.4 年增加到 9.6 年。活体供者和已故供者的肝移植后肾移植的 1、3 和 5 年实际移植物存活率均低于单纯肾移植患者。但是,无死亡事件的移植物存活率则相同。患者存活率也较低,但与未发生 ESRD 的肝移植患者相似。2008 年,在美国进行的所有单纯肾移植中,肝移植后肾移植仅占 0.9%。
对于因肝移植后发生 ESRD 而需要治疗的患者,肾移植是一种合适的治疗方法。